Sleep Disorders Trial, Recruiting NCT07089797 Sponsor: The University of Hong Kong Condition: Sleep Disorders
Back to Sleep Disorders

Sleep Disorders Trial, Recruiting

NCT07089797
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People aged 18 or older
  • People who are an unpaid caregiver (such as a family member or friend) who lives with someone who has had cancer at any stage, and who provides at least 4 hours of care per day — if more than one caregiver is available for the same person with cancer, the one providing the most daily care would be considered
  • People who can understand the research procedures and are able to read and communicate in Chinese
  • People who are able to use the WeChat app
  • People whose sleep difficulty score on a standard screening questionnaire (called the Insomnia Severity Index) is above 7, indicating notable sleep problems

Who may not be able to join:

  • People who have another untreated or poorly managed sleep disorder besides insomnia, such as sleep apnoea, restless leg syndrome, or a disorder affecting movement during sleep
  • People who have a psychotic disorder such as bipolar disorder or schizophrenia, or who have had thoughts of suicide with a plan and intent, or have attempted suicide in the past 2 months
  • People who are currently taking psychiatric or mental health medications, such as antidepressants, anti-anxiety medications, or sleeping tablets
  • People who have an unstable or serious medical condition, who are expecting surgery within the next 6 months, who are pregnant, or who have epilepsy
  • People who are currently taking part in another interventional program or study
  • People who have previously received a structured sleep therapy called CBT-I (Cognitive Behavioural Therapy for Insomnia)
  • People who work night shifts, evening shifts, early morning shifts, or rotating shift schedules
  • People who are currently caring for a cancer patient who is receiving hospice (end-of-life) care

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +85263581459

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
11 August 2025
Est. completion
1 June 2026

Where this trial is recruiting

🇨🇳 China

Primary endpoints

Insomnia severity

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov